- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: CD19.CAR-CD28Z T Cells - dose escalation 1
Total 302 results
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | High Grade B-Cell Non-Hodgkin's Lymphoma | Intermediate Grade B-Cell Non-Hodgkin's LymphomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); Novartis; Secura Bio, Inc.RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
National University of MalaysiaGaia ScienceRecruitingRelapsed B Acute Lymphoblastic Leukaemia | Refractory B Acute Lymphoblastic LeukaemiaMalaysia
-
University Hospital HeidelbergRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Acute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, AdultGermany
-
Benjamin TomlinsonRecruitingAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Yanda Ludaopei HospitalRecruitingCD19+ and CD 22+ B-ALLChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Recruiting
-
Henan Cancer HospitalThe Beijing Pregene Science and Technology Company, Ltd.UnknownB-cell Acute Lymphoblastic LeukemiaChina
-
Hrain Biotechnology Co., Ltd.Shanghai Changzheng HospitalActive, not recruitingPOMES Syndrome | Relapsed and Refractory POMES SyndromeChina
-
The Second Affiliated Hospital of Henan University...First Affiliated Hospital of Wenzhou Medical University; Second Affiliated... and other collaboratorsUnknown
-
Shanghai General Hospital, Shanghai Jiao Tong University...CompletedAcute Lymphoblastic Leukemia | MRD-positiveChina
-
Peng LiuShanghai East Hospital; Hrain BiotechnologyUnknownMultiple Myeloma in Relapse | Multiple Myeloma ProgressionChina
-
Shenzhen Second People's HospitalShenzhen Institute for Innovation and Translational MedicineUnknownLymphoma | Chronic Lymphocytic Leukemia | Acute Lymphocytic LeukemiaChina
-
National Cancer Institute (NCI)RecruitingLymphoma, Non-Hodgkin | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Acute Lymphoid Leukemia | B-Cell Leukemia | Leukemia, Lymphocytic, B Cell | B-Cell Lymphoma | B-All | B-NHL | B-Non Hodgkin LymphomaUnited States
-
Loyola UniversityLeukemia Research FoundationActive, not recruitingB-Cell Acute Lymphoblastic Leukemia, Adult | B-cell Lymphoma Refractory | B-cell Lymphoma RecurrentUnited States
-
Sabz BiomedicalsGene Therapy Research Center, Shariati Hospital, Tehran University of Medical... and other collaboratorsNot yet recruitingRelapsed B Cell Acute Lymphoblastic Leukemia (ALL) | Refractory B Cell Acute Lymphoblastic Leukemia (ALL)Iran, Islamic Republic of
-
National Cancer Institute (NCI)RecruitingLymphoma, B-Cell | Chronic Lymphocytic Leukemia | B-Cell Chronic Lymphocytic LeukemiaUnited States
-
Shanghai Ming Ju Biotechnology Co., Ltd.RecruitingAcute Lymphocytic LeukemiaChina
-
Shanxi Province Cancer HospitalShanghai Ultra-T Immune Therapeutics Co. LTDRecruitingAcute Lymphocytic Leukemia, B-CellChina
-
Shanxi Province Cancer HospitalNovatim Immune Therapeutics (Zhejiang) Co., Ltd.Recruiting
-
The First Affiliated Hospital of Soochow UniversityWest China Hospital; Affiliated Hospital of Jiangnan University; The Affiliated... and other collaboratorsRecruitingRelapsed/Refractory B-cell Non-Hodgkin's LymphomaChina
-
National Cancer Institute (NCI)RecruitingLymphoma, Non-Hodgkin | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Acute Lymphoid Leukemia | B-Cell Leukemia | Leukemia, Lymphocytic, B Cell | B-Cell Lymphoma | B-All | B-NHL | B-Non Hodgkin Lymphoma | B-precursor ALLUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
National Cancer Institute (NCI)Not yet recruitingLeukemia, Lymphocytic, Chronic, B-Cell | B-Cell Chronic Lymphocytic Leukemia | B-Lymphocytic Leukemia, ChronicUnited States
-
Medical University of South CarolinaRecruitingChronic Lymphocytic Leukemia | B-cell Non Hodgkin LymphomaUnited States
-
University College, LondonActive, not recruitingBurkitt Lymphoma | Acute Lymphoblastic LeukemiaUnited Kingdom
-
Chinese PLA General HospitalPeking University; EdiGene Inc.RecruitingNon Hodgkin's LymphomaChina
-
Chinese PLA General HospitalRecruitingNon-hodgkin LymphomaChina
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - WHO Class IV | Lupus Nephritis - WHO Class IIIGermany
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - World Health Organization (WHO) Class III | Lupus Nephritis - WHO Class IVUnited States
-
National Cancer Institute (NCI)TerminatedLymphoma, B-Cell | Chronic Lymphocytic Leukemia | Lymphoma, Non-hodgkins | B-Cell Chronic Lymphocytic LeukemiaUnited States
-
St. Jude Children's Research HospitalRecruitingPediatric ALL | Acute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia, RefractoryUnited States
-
St. Jude Children's Research HospitalActive, not recruitingAcute Lymphoblastic Leukemia, in Relapse | Acute Lymphoblastic Leukemia, RefractoryUnited States
-
National Cancer Institute (NCI)CompletedT Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell MalignanciesLymphoma, B-Cell | Lymphoma, Non-hodgkinsUnited States
-
Bruce CreeKyverna TherapeuticsRecruitingProgressive Multiple SclerosisUnited States
-
CARsgen Therapeutics Co., Ltd.Fudan University; Peking University Cancer Hospital & InstituteRecruitingStudy to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell InjectionPancreatic Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaChina
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Genentech, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Follic Lymph to Diff Large B-Cell Lymphoma | Transformed Marg Zone Lymph to Diff...United States
-
Imugene LimitedRecruitingNon-Hodgkin Lymphoma | B-cell Acute Lymphoblastic LeukemiaUnited States
-
University of LeedsRecruitingInflammatory ArthritisUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyActive, not recruitingMultiple MyelomaUnited States
-
Chongqing University Cancer HospitalFundamenta Therapeutics, Ltd.Not yet recruitingRefractory or Relapsed B Cell LymphomaChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingB Acute Lymphoblastic LeukemiaUnited States
-
Wuhan Union Hospital, ChinaCSPC Pharmaceutical Group LimitedRecruitingB-cell Acute Lymphoblastic Leukemia | B-cell Lymphoma RefractoryChina
-
C. Babis AndreadisUniversity of California, DavisRecruitingFollicular Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Lymphoplasmacytic Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Transformed LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMalignant Brain Neoplasm | Recurrent Malignant Brain Neoplasm | Refractory Malignant Brain NeoplasmUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingChronic Graft Versus Host Disease | Hematologic and Lymphocytic Disorder | Steroid Refractory Graft Versus Host DiseaseUnited States
-
Malaghan Institute of Medical ResearchWellington Zhaotai Therapies LimitedActive, not recruitingMantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)New Zealand
-
Fred Hutchinson Cancer CenterJuno Therapeutics, Inc., a Bristol-Myers Squibb CompanyTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Adult Acute Lymphoblastic Leukemia | Refractory Diffuse... and other conditionsUnited States
-
Boryung Pharmaceutical Co., LtdCompletedProstate CancerKorea, Republic of
-
Tasly Pharmaceutical Group Co., LtdRecruiting